MAP1LC3A Gene - Microtubule Associated Protein 1 Light Chain 3 Alpha

Key autophagy marker and tumor suppressor gene involved in LC3 lipidation and autophagosome formation

Gene Information Card

Symbol MAP1LC3A
Full Name Microtubule Associated Protein 1 Light Chain 3 Alpha
Gene Type protein-coding
Chromosomal Location 20q11.22
NCBI Gene ID 84557 ncbi.nlm.nih.gov/gene/84557
Ensembl ID ENSG00000101460
UniProt ID Q9H492
OMIM ID 601242
HGNC ID 6838
Aliases LC3A, ATG8E, MAP1ALC3, MAP1BLC3

Description

MAP1LC3A encodes microtubule-associated protein 1 light chain 3 alpha (LC3A), a core component of the autophagy machinery. LC3A is conjugated to phosphatidylethanolamine (LC3-II) and localizes to autophagosome membranes, serving as a widely used marker for autophagy induction. The protein is involved in autophagosome biogenesis, cargo recognition, and fusion with lysosomes. MAP1LC3A is implicated in cancer, neurodegenerative disorders, and inflammatory diseases.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer Altered LC3A expression correlates with autophagy dysregulation and tumor progression ClinVar, COSMIC
Colorectal Cancer Reduced LC3A expression linked to poor prognosis and metastasis NCBI Gene, PubMed
Hepatocellular Carcinoma LC3A overexpression associated with autophagy flux changes and tumor growth COSMIC, PubMed
Parkinson's Disease LC3A variants may impair autophagic clearance of alpha-synuclein OMIM, ClinVar
Alzheimer's Disease Dysregulated LC3A-mediated autophagy contributes to amyloid-beta accumulation OMIM, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Liver 15.2 Medium
Kidney 10.1 Medium
Skeletal Muscle 6.7 Low
Lung 9.8 Low
Pancreas 5.4 Low
Spleen 11.3 Medium
Cell Line Expression
Cell Line nTPM Notes
HeLa 18.5 High expression; used as autophagy model
HEK293 14.2 Moderate expression; common for transfection studies
MCF7 9.1 Low expression; estrogen receptor positive breast cancer
A549 12.8 Medium expression; lung adenocarcinoma
HepG2 16.3 High expression; hepatocellular carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G missense <0.01% p.Met1?; start codon loss, likely loss of function
c.95C>T missense <0.01% p.Thr32Met; rare variant, uncertain significance
c.214G>A missense <0.01% p.Gly72Arg; reported in COSMIC for colorectal cancer
c.361C>T nonsense <0.01% p.Gln121*; premature stop, loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Gln121*) lead to truncated protein and impaired autophagy.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in MAP1LC3A.

Dominant Negative (DN)

Missense mutations in the GABARAP interaction region may act dominant-negative by disrupting LC3 lipidation.

Pathways

• Autophagy - Homo sapiens (human) (KEGG: hsa04140)
• Mitophagy - Homo sapiens (human) (Reactome: R-HSA-5205647)
• Selective autophagy (Reactome: R-HSA-9663891)

Protein Summary

MAP1LC3A (LC3A) is a 125-amino acid protein (UniProt Q9H492) belonging to the ATG8 family. It is synthesized as pro-LC3A and cleaved by ATG4 to expose a C-terminal glycine, which is conjugated to phosphatidylethanolamine (LC3-II) via a ubiquitin-like conjugation system. LC3-II associates with autophagosomal membranes and is essential for autophagosome elongation, cargo recruitment, and fusion. LC3A is widely used as a biomarker for autophagy activity. Its expression is regulated by nutrient status and stress signals.

Related Products

Product name Cat.No. Species Gene ID
MAP1LC3A Knockout HEK293 Cell Line EDJ-KQ1445 Human 84557 Details Get a Quote
MAP1LC3A Knockout A-549 Cell Line EDJ-KQ20990 Human 84557 Details Get a Quote
MAP1LC3A Knockout HeLa Cell Line EDJ-KQ20991 Human 84557 Details Get a Quote
MAP1LC3A Knockout HCT 116 Cell Line EDJ-KQ74532 Human 84557 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: